A large amount of evidence supports the widespread use of transcatheter aortic valve
replacement (TAVR) among patients who are at low to intermediate risk for surgery …

Transcatheter aortic valve replacement (TAVR) is a treatment option for symptomatic
patients with severe aortic stenosis who are candidates for a bioprosthesis across the entire …

Transcatheter aortic valve implantation (TAVI) is the standard of care for symptomatic severe
aortic stenosis. Antithrombotic therapy is required after TAVI to prevent thrombotic …

Importance Transcatheter aortic valve replacement (TAVR) is an established alternative to
surgery for patients with severe symptomatic aortic stenosis. Adjunctive antithrombotic …

Background Several trials demonstrated that aspirin monotherapy compared with aspirin
plus clopidogrel is associated with a lower incidence of bleeding without an increased risk of …

Transcatheter aortic valve implantation (TAVI) has emerged as a therapeutic alternative for
patients with symptomatic aortic stenosis at high or prohibitive surgical risk. However …

Transcatheter aortic valve implantation (TAVI) has emerged as a valuable treatment
alternative to surgical aortic valve replacement among patients with symptomatic aortic …

Transcatheter aortic valve replacement (TAVR) has gained over time a major reduction in
procedural complications. Despite this, clinically relevant bleeding still occurs in a non …

Transcatheter aortic valve implantation (TAVI) is effective in older patients with symptomatic
severe aortic stenosis, while the indication has recently broadened to younger patients at …

Importance Subclinical leaflet thrombosis affects approximately 15% of patients after
transcatheter aortic valve replacement (TAVR). The pathophysiology and clinical …